Xiangnan Li

2.6k citations
57 papers · 783 indexed · 1 hit paper · h-index 17
Topics
RNA modifications and cancer (7 papers)Cardiac Imaging and Diagnostics (5 papers)Esophageal Cancer Research and Treatment (5 papers)

In The Last Decade

Xiangnan Li

53 papers receiving 771 citations

Hit Papers

Ratio of Red Blood Cell Distribution Width to Albumin Lev...202420262025202410203040

Peers

Xiangnan Li
Comparison fields: 5 of 107
  • Molecular Biology 215
  • Oncology 97
  • Electrical and Electronic Engineering 88
  • Renewable Energy, Sustainability and the Environment 83
  • Immunology 78
Replace Zhuo Chen with:
Zhuo Chen China
Minna Liu China
Jianhua He China
Jiaqi Tang China
Kang Zhou China
Xifeng Lu China
Yayun Nan China
Yueqiu Wang China
Liyuan Peng China
Weishuai Lian China
Xiangnan Li relative to Zhuo Chen China Zhuo Chen's profile →
Citations per field
00.5×3.5×
Zhuo Chen · 1×
Citations per year

Countries citing papers authored by Xiangnan Li

Since Specialization
Citations

This map shows the geographic impact of Xiangnan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangnan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangnan Li more than expected).

Fields of papers citing papers by Xiangnan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangnan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangnan Li. The network helps show where Xiangnan Li may publish in the future.

Co-authorship network of co-authors of Xiangnan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangnan Li. A scholar is included among the top collaborators of Xiangnan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangnan Li. Xiangnan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 1
4 1
5 1
6 1
7 1
8 19
9 4
10 7
11 1
12 5
13 9
14 4
15 1
16 16
17 33
18 19
19 38
20 3

About Xiangnan Li

Xiangnan Li is a scholar working on Nephrology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 57 papers that have together received 783 indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Cardiac Imaging and Diagnostics (5 papers) and Esophageal Cancer Research and Treatment (5 papers). The work is most often cited by research in Nephrology (54 citations), Ophthalmology (69 citations) and Renewable Energy, Sustainability and the Environment (83 citations). Xiangnan Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Junhui Du, Yang Yao, Rong Li, Fangyu Zhu, Yu Zhao, Siyu Chen, Na Luo, Liufan Yin, Jianhua Gan and Qiang Luo. Their work appears in journals such as Nucleic Acids Research, The Journal of Immunology and Journal of Materials Chemistry A.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026